The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Powell, N. D.
Right arrow Articles by Whitacre, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Powell, N. D.
Right arrow Articles by Whitacre, C. C.
The Journal of Immunology, 2005, 175: 5611-5614.
Copyright © 2005 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: Macrophage Migration Inhibitory Factor Is Necessary for Progression of Experimental Autoimmune Encephalomyelitis1

Nicole D. Powell*, Tracey L. Papenfuss*, Melanie A. McClain*, Ingrid E. Gienapp*, Todd M. Shawler*, Abhay R. Satoskar{dagger} and Caroline C. Whitacre2,*

* Department of Molecular Virology, Immunology, and Medical Genetics and {dagger} Department of Microbiology, The Ohio State University, Columbus, OH 43210

Macrophage migration inhibitory factor (MIF) has been implicated in the pathogenesis of inflammatory and autoimmune diseases. The role of MIF in the progression of experimental autoimmune encephalomyelitis (EAE) was explored using MIF–/– mice. Wild-type mice showed a progressive disease course, whereas MIF–/– mice exhibited acute signs but no further progression of clinical disease. MIF–/– mice displayed markedly elevated corticosterone levels and significant decreases in the inflammatory cytokines TNF-{alpha}, IFN-{gamma}, IL-2, and IL-6 before, during, and after EAE onset. Taken together, these findings support that MIF is an important mediator of EAE progression through glucocorticoid antagonism and up-regulation of the inflammatory response.


Related articles in The JI:

IN THIS ISSUE

The JI 2005 175: 5565-5566. [Full Text]  



This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
C. A. Learn, P. E. Fecci, R. J. Schmittling, W. Xie, I. Karikari, D. A. Mitchell, G. E. Archer, Z. Wei, H. Dressman, and J. H. Sampson
Profiling of CD4+, CD8+, and CD4+CD25+CD45RO+FoxP3+ T Cells in Patients with Malignant Glioma Reveals Differential Expression of the Immunologic Transcriptome Compared with T Cells from Healthy Volunteers
Clin. Cancer Res., December 15, 2006; 12(24): 7306 - 7315.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.